No photo of Mirva Johanna Hannula

Mirva Johanna Hannula

If you made any changes in Pure these will be visible here soon.

Personal profile


  • 317 Pharmacy

Publications 2011 2019

New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases

Svarcbahs, R., Julku, U., Kilpelainen, T., Kyyrö, M., Jäntti, M. & Myohänen, T. T., Mar 2019, In : Biochemical Pharmacology. 161, p. 113-120 8 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

Myöhänen, T. T., Hannula, M. J., Van Elzen, R., Gerard, M., Van der Veken, P., Garcia Horsman, J. A., Baekelandt, V., Männistö, P. T. & Lambeir, A. M., 10 Jan 2012, In : British Journal of Pharmacology. 166, 3, p. 1097-1113 17 p.

Research output: Contribution to journalArticleScientificpeer-review

Projects 2013 2014

Activities 2010 2010

  • 1 Supervisor or co-supervisor of doctoral thesis

Prolyylioligopeptidaasi ja sen estäminen alfa-synukleiiniin perustuvissa Parkinsonin taudin malleissa

Timo Myöhänen (Supervisor)

Activity: Examination typesSupervisor or co-supervisor of doctoral thesis